✦ LIBER ✦

P.3.a.010 The use of the 16 item Negative Symptom Assessment (NSA-16) by videoconferencing in a clinical trial

✍ Scribed by J.B.W. Williams; D. Popp; D.A. Osman; E.A. Cohen; M.J. Detke

Book ID: 118599268
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 60 KB
Volume: 22
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(12)70472-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Poster #177 THE USE OF THE NSA-16 BY VID

Poster #177 THE USE OF THE NSA-16 BY VIDEOCONFERENCING IN A CLINICAL TRIAL

✍ Williams, JBW; Popp, D.; Osman, DA; Cohen, E.A.; Detke, M.J. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 87 KB

P.3.a.033 Association between changes on

P.3.a.033 Association between changes on the Negative Symptom Assessment-16 scale (NSA-16) and functional outcomes in schizophrenia

✍ D.I. Velligan; M. Wang; G. Haig; S. Lancaster; T.N. Taylor; L. Alphs 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

11 – Use of the 4-item Negative Symptom

11 – Use of the 4-item Negative Symptom Assessment (NSA-4) by minimally trained clinicians

✍ A. Van Willigenburg; L. Alphs; R. Morlock; J. Panagides 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

1922 – The evaluation of negative sympto

1922 – The evaluation of negative symptoms by videoconferencing in a clinical trial

✍ Williams, J.B.W.; Popp, D.; Osman, D.A.; Cohen, E.A.; Detke, M.J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 30 KB

Validation of a 4-item Negative Symptom

Validation of a 4-item Negative Symptom Assessment (NSA-4): a short, practical clinical tool for the assessment of negative symptoms in schizophrenia

✍ Larry Alphs; Robert Morlock; Cheryl Coon; Pilar Cazorla; Armin Szegedi; John Pan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

The 16-item Negative Symptom Assessment (NSA-16) scale is a validated tool for evaluating negative symptoms of schizophrenia. The psychometric properties and predictive power of a four-item version (NSA-4) were compared with the NSA-16. Baseline data from 561 patients with predominant negative sympt

P44 Is tumor-biological risk-assessment

P44 Is tumor-biological risk-assessment realistic in node-negative breast cancer? A status report of the ongoing clinical multicenter trial NNBC-3-Europe

✍ M. Persing; N. Harbeck; M. Vetter; A. Guerts; M. Zerm; D. Paepke; M. Schmidt; C. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB